Markets:

Overview

News

Currencies

International

Treasuries

Eaton Vance Ohio Municipal Income Trust (NQ:EVO)

2.690 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eaton Vance Ohio Municipal Income Trust

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Evotec welcomes Aurélie Dalbiez as Chief People Officer

April 16, 2024

Via ACCESSWIRE

Finding the Next Big Winners: 7 Stocks You Can Snag for Under $10 ↗

March 20, 2024

Looking for stocks under $10? Here are seven great bargain picks that you can buy for less than $10 per share today.

Via InvestorPlace

3 Stocks Set to Double: Your Fast Track to 2024 Gains ↗

March 06, 2024

Looking for bargains in the market right now? These three stocks could be set to double in coming months.

Via InvestorPlace

Evotec And Claris Ventures Streamline Access to Accelerate Programmes from Claris's Portfolio Companies into The Clinic

March 05, 2024

Via ACCESSWIRE

7 Stable Stocks to Buy for 100% Returns by 2025 ↗

March 04, 2024

If you're looking for stability and the opportunity to double your returns by the time 2025 rolls around, check out these stable stocks.

Via InvestorPlace

Evotec SE: Invitation to Conference Call

January 21, 2024

Via ACCESSWIRE

A Preview Of Evotec's Earnings ↗

November 07, 2023

Via Benzinga

The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore. ↗

February 15, 2024

Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.

Via InvestorPlace

Just - Evotec Biologics Expands Development and Manufacturing Agreement with ABL for Broadly Neutralising Antibodies Against HIV

February 06, 2024

Via ACCESSWIRE

What's Going On With Life Science Company Evotec Stock Today? ↗

January 10, 2024

Evotec SE (NASDAQ: EVO) joined forces with the Crohn's & Colitis Foundation to advance drug discovery and identify novel therapies for inflammatory bowel disease (IBD).

Via Benzinga

Evotec and Crohn's & Colitis Foundation Enter Agreement to Advance Drug Discovery for Novel IBD Therapies

January 10, 2024

Via ACCESSWIRE

Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb

January 07, 2024

Via ACCESSWIRE

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 04, 2024

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23 financial results and initial 2024 guidance.<

Via Benzinga

Why Is Mobileye (MBLY) Stock Down 26% Today? ↗

January 04, 2024

Mobileye stock is taking a beating on Thursday with investors in MBLY bemoaning the company's revenue outlook for the year.

Via InvestorPlace

Can TikTok Save Peloton (PTON) Stock? ↗

January 04, 2024

Peloton stock is heading higher on Thursday as investors in PTON react to the company signing a new partnership with TikTok.

Via InvestorPlace

Why Is Evotec (EVO) Stock Down 12% Today? ↗

January 04, 2024

Evotec stock is falling on Thursday with heavy trading of EVO shares following the resignation of the company's CEO, Dr. Werner Lanthaler.

Via InvestorPlace

Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗

January 04, 2024

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

January 04, 2024

Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!

Via InvestorPlace

Why Germany-Based Life Science Company Evotec Shares Are Falling Today ↗

January 04, 2024

Evotec SE (NASDAQ: EVO) shares are trading lower

Via Benzinga

Cal-Maine Posts Downbeat Q2 Results, Joins Dyne Therapeutics, OPKO Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

January 04, 2024

U.S. stock futures were higher this morning, with the Dow Jones futures gaining around 50 points on Thursday.

Via Benzinga

Topics Stocks

Evotec and Owkin Enter an A.I.-Powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I

January 03, 2024

Via ACCESSWIRE

Evotec Announces CEO Transition

January 03, 2024

Via ACCESSWIRE

Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes

December 18, 2023

Via ACCESSWIRE

Evotec Enters Partnership with Charité to Expand Molecular Patient Database in Autoimmune Diseases

December 14, 2023

Via ACCESSWIRE

Evotec-partner Jingxin Receives Approval for EVT201 in China

December 06, 2023

Via ACCESSWIRE

Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day

November 15, 2023

Via ACCESSWIRE

Evotec SE Reports Results for the First Nine Months 2023 and Provides Corporate Update

November 08, 2023

Via ACCESSWIRE

Evotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncology

November 07, 2023

Via ACCESSWIRE

Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'

October 05, 2023

Via ACCESSWIRE

Evotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D Economy

September 27, 2023

Via ACCESSWIRE

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.